©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Molecular Cloning and Expression of an Avian Macrophage Nitric-oxide Synthase cDNA and the Analysis of the Genomic 5`-Flanking Region (*)

(Received for publication, October 20, 1995; and in revised form, March 7, 1996)

Arthur W. Lin Christine C. Chang Charles C. McCormick (§)

From the Division of Nutritional Sciences, Cornell University, Ithaca, New York 14853

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

We report the first nonmammalian inducible nitric-oxide synthase (NOS) cDNA obtained from chicken macrophages. It exhibits an open reading frame encoding 1,136 amino acid residues, predicting a protein of 129,648-Da molecular mass. The deduced NOS protein sequence showed 66.6%, 70.4%, 54.2%, and 48.7% sequence identity to mouse and human inducible NOS and to two constitutive NOSs from rat brain and bovine endothelium. Overall, NOS appears to be a moderately conserved protein. Northern analysis showed that chicken iNOS mRNA is approximately 4.5 kilobases (kb), a size similar to mammalian inducible NOS. Analysis of 3.2 kb of 5`-flanking sequence of the chicken iNOS gene showed a putative TATA box at 30 base pairs (bp) upstream of the transcription initiation site. The functional importance of the upstream region was determined by transient expression of deletion constructs. An endotoxin regulatory region was located exclusively within 300 bp upstream of the transcription initiation site. This is in contrast to the two distinct sites identified in the mouse macrophage NOS promoter. Transcription factor binding sites such as NF-kappaB, PEA1, PEA3, and C/EBP were identified. Using a NF-kappaB inhibitor, we showed that NF-kappaB is indeed involved in the induction of chicken iNOS gene by lipopolysaccharide. Our results suggest that NF-kappaB is a common regulatory component in the expression of both mammalian and nonmammalian iNOS genes.


INTRODUCTION

The oxidation of L-arginine (1, 2, 3) is now recognized to be an important biochemical pathway in many organisms. One of the products of this reaction, nitric oxide (NO), (^1)performs many diverse and significant biological functions(4, 5, 6, 7, 8) . In the nervous system, NO is a novel neurotransmitter (9, 10, 11) which is synthesized as needed and not stored in synaptic vesicles. Importantly, nitric oxide does not interact with receptors on the surface of neurons but targets redox centers within neighboring neurons. In the vascular system, NO acts as the endothelium-derived relaxing factor (12, 13) which is a mediator of blood vessel relaxation and blood pressure. It can also inhibit platelet aggregation (14) and adhesion. In the immune system, NO is synthesized by activated macrophages and acts as a cytotoxic and tumoricidal agent(1, 2, 5) . NO also mediates important functions in other tissues and organs such as the gastrointestinal tract(15) , liver (16) , pancreas(17) , kidney(18) , and the reproductive system(19) .

The enzyme, nitric-oxide synthase (NOS), which catalyzes the biosynthesis of NO has been purified(20, 21, 22, 23) , and its cDNA cloned in mammals from the brain(24, 25) , endothelium(26, 27, 28, 29, 30) , macrophage (31, 32) , and hepatocyte(33) . There are, at least, three genetically distinct types of NOS: type 1 (nNOS), a constitutive form which was initially identified in neurons; type 2 (iNOS), an inducible form from macrophages, and type 3 (eNOS), a constitutive form which was initially identified in endothelium. All isoforms utilize the amino acid arginine, molecular oxygen, and NADPH as substrates and require tetrahydrobiopterin, FAD, and FMN as cofactors(3) . The two constitutive forms are activated by and dependent on changes in intracellular calcium(5) , whereas the inducible isoform is calcium independent apparently because calmodulin is a tightly bound subunit of the iNOS(34) .

Although there has been considerable research on the biological functions of NO and the regulation of NOS in humans and rodents(35) , little is known of NOS in any nonmammalian system. It has been reported that other species are capable of producing NO, such as Limulus polyphemus(35) , hematophagous insects(36) , fish(37) , and chickens(38) . In addition, there is a single report of a primary structure of the constitutive NOS from Drosophila(39) but there are no known NOS sequences from other nonmammalian species. This has not only impeded the understanding the evolution of NOS protein but also made the study of the regulation of NOS at the molecular level in other species impossible. Since chickens do not possess the urea cycle (40) and thus can not synthesize the substrate of NOS (arginine) directly, the chick represents a unique and potentially important model to study NOS gene expression. In an effort to study NOS regulation and to evaluate the evolution of NOS, we have cloned the first nonmammalian inducible NOS cDNA from a chicken macrophage cell line. In addition, we report the cloning and analysis of chicken iNOS 5`-flanking region. We have identified an upstream region of chicken iNOS gene responsible for LPS stimulation. In this LPS-responsive region, several transcription factor binding elements were identified, but NF-kappaB was shown to be involved in the induction of chicken iNOS gene expression.


MATERIALS AND METHODS

Cell Culture

The chicken macrophage cell line, HD11(41) , was kindly provided by Dr. Dietert (Cornell University, Ithaca). Cells were maintained at 37 °C, 5% CO(2) in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% low endotoxin fetal bovine serum (Hyclone Laboratories, Logan, UT), penicillin, and streptomycin. LPS (Escherichia coli, serotype 0128:B12) was purchased from Sigma, prepared in DMEM medium at 1 mg/ml, and stored at -80 °C prior to use. All other reagents were purchased from Sigma unless otherwise indicated.

Reverse Transcription-PCR to Generate a Probe for cDNA Library Screening

Highly degenerate oligonucleotides were deduced from conserved amino acid residues between rat neuronal NOS (24) and mouse macrophage NOS (31, 32) sequences for polymerase chain reaction. The reaction was performed by using total RNA from LPS-induced chicken macrophages, HD11. The two degenerate primers were: the sense strand, ITPVFHQEM (ATIACICCIGTITTICAICAIGAIATG), corresponding to amino acids 466-474 in mouse iNOS; the antisense strand, ATETGKS (CGITGICTITGICCITTIAG), corresponding to amino acids 538-544 in mouse iNOS. Restriction enzymes, EcoRI and HindIII, recognition sequences were flanked at the 5` end of the primer sequences for subcloning purpose. A reverse transcription-PCR kit (Perkin-Elmer) was used with the renature temperature 50 °C for 40 cycles. The PCR product was further subcloned in Bluescript plasmids (Stratagene), sequenced, and used as a probe for cDNA library screening.

cDNA Library Screening

The cDNA library was made commercially (Stratagene) by using 500 µg of total RNA isolated from chicken macrophages stimulated with LPS (100 ng/ml) for 12 h. The cDNA library was constructed in ZAPII phages by using random priming and poly(A) priming on chicken macrophage mRNA. Phages were plated on E. coli strain MRF and further transferred onto Dulose membranes (Stratagene). The membranes were hybridized in 2 times PIPES, 50% deionized formamide, 0.5% SDS, 100 µg/ml denatured, sonicated salmon sperm DNA, and random priming [P]CTP-labeled PCR product (1 million cpm/ml) at 42 °C for at least 18 h. Membranes were washed in 0.5 times SSC and 0.1% SDS at 60 °C until radioactivity on membranes was below 1,000 cpm and then exposed to x-ray films for at least 8 h before developing. Approximately 1 million independent clones were screened and several dozen positive clones identified. Positive clones were successively spread and screened until pure clones were obtained. Twenty-four positive clones were further rescued to Bluescript plasmids as described by the manufacturer's procedures (Stratagene) for restriction enzyme digestion and DNA sequencing. Manual DNA sequencing was done using Sequenase 2.0 kits. (U. S. Biochemical Corp.) and verified using the automated sequencing facility at Cornell University (Applied Biosystems).

Northern Blot Analysis

Total RNA was isolated using guanidine thiocyanate in a single step method(42) , fractionated on a denaturing, 1% agarose gel, and transferred onto a GeneScreen Plus membrane (DuPont NEN). The blot was hybridized at 42 °C in 5 times SSPE, 5 times Denhardt's solution, 0.1% SDS, 100 µg/ml salmon sperm DNA, 50% deionized formamide, and probed with [P]CTP-labeled chicken iNOS cDNA (1 million cpm/ml). The probe was labeled by random priming. Membranes were washed at high stringency: 0.1 times SSPE, 0.1% SDS at 45 °C. The blot was exposed to x-ray films at -80 °C for at least 24 h before developing.

Transient Expression

The chick iNOS cDNA which contained a full open reading frame obtained from cDNA library screening was excised at the EcoRI restriction enzyme site and subcloned into an eukaryotic expression vector, pcDNA3 (Invitrogen). The expression vector containing chick iNOS cDNA was transiently transfected into COS-1 cells by lipofection (LipofectAMINE, Life Technologies, Inc.). COS-1 cells, 1-1.2 times 10^5 cells, were seeded in each well on a 6-well plate 1 6 to 24 h prior to transfection. Cells were incubated at 37 °C (5% CO(2)) until 50-60% confluence. Prior to transfection, cells were washed with DMEM without serum at least three times, and 2.4 µg of DNA and 12 µl of LipofectAMINE were added into culture dishes with DMEM alone. Five h later, an equal amount of DMEM plus 20% fetal calf serum with no antibiotics was added to each well. After 12 to 24 h, the medium was changed back to DMEM plus 10% fetal calf serum plus antibiotics with or without inhibitor (100 µML-NMMA or aminoguanidine) and with or without L- or D-arginine (1 mM). Two to three days after transfection, the cell culture supernatant was taken for nitrite analysis.

Nitrite Determination

Nitrite was measured as described by Green et al.(43) . 100 µl of cell culture supernatant was added to 100 µl of Griess reagent (1;1, v/v, 0.1% N-(1-naphthyl)ethylenediamine and 1% sulfanilamide in 5% H(3)PO(4)) in a 96-well flat-bottomed plate. The reading of absorbance at 550 nm was taken using medium as blank. Nitrite concentration was obtained by comparison with NaNO(2) standard curve.

Genomic Library Screening

An amplified genomic library derived from an adult Leghorn male chicken was purchased from Clontech (La Jolla, CA). The iNOS cDNA containing a full open reading frame was used as a probe and labeled by random priming. Screening procedures were followed according to the library protocol handbook from Clontech with minor modifications. Briefly, 30,000 to 40,000 plaques were seeded in each 150-mm Petri dish. Two million clones were screened, and duplicate membranes were used through screenings. Membranes were hybridized in 2 times PIPES, 50% deionized formamide, 0.5% SDS, and 100 µg/ml denatured, sheared salmon sperm DNA at 42 °C for at least 16 h. Membranes were washed using the following conditions: twice (15 min each) at room temperature in 2 times SSC, 0.1% SDS; twice (15 min each) at 42 °C in 2 times SSC, 0.1% SDS; twice (15 min each) at 65 °C in 2 times SSC, 0.1% SDS. After membranes were washed, a Geiger counter was used to estimate the intensity of the signal and the background. If the background radioactivity was over 2,000 cpm, then the membranes would be washed another 3 times (15 min each) at 65 °C at 2 times SSC, 0.1% SDS. Membranes were then exposed to x-ray films (X-Omar film, Kodak) at -70 °C for at least 16 h. Positive plaques were rescreened by the same procedures until pure clones were obtained. Eight positive clones were obtained, and DNA from positive clones was purified. Restriction enzyme analyses (data not shown) indicated that these eight positive clones belonged to four independent clones.

Cloning the 5`-Flanking Region of iNOS Gene

DNA from the four independent genomic clones was subject to PCR reaction to identify the clones containing 5`-flanking sequence of chicken iNOS gene. A pair of primers were synthesized corresponding to the 5` end sequences of iNOS cDNA with sense strand, TTCAAACCTCATGCTGTTAA (corresponding to most of amino acid residues 8-15); antisense strand, GATTATAGGTGACATCTTCA (corresponding to most of amino acid residues 52-58). The PCR reaction was set at an annealing temperature of 60 °C for 25 cycles. After PCR reactions, 10 µl of PCR product was analyzed on an agarose gel (1%) along with DNA molecular weight markers. Among these four positive clones, only one clone possessed the 5`-flanking sequence of chicken iNOS gene (data not shown). phage DNA from this positive clone was digested by four different restriction enzymes, BamHI, EcoRI, XbaI, and SacI, and subcloned into Bluescript plasmid at the respective restriction enzyme sites. After subcloning, plasmids were transformed into E. coli cells (DH5alpha) and spread on ampicillin agar plates. Twelve colonies were randomly picked from each subcloning group, and their plasmids were isolated. PCR was used again to identify the colonies containing the 5`-flanking sequences of iNOS gene. Two colonies, one in the XbaI group and one in the SacI group, were identified to contain the 5`-flanking region of iNOS gene. The 5`-flanking region of iNOS was sequenced on both strands by a Sequenase 2.0 kit (U.S. Biochemical Corp.). The sequences were confirmed by the automated sequencing facility at Cornell University (Applied Biosystems). DNA sequence analysis identified that the one in the SacI group possessed the longer 5`-flanking sequence of iNOS gene than that of the XbaI group.

Mapping the Transcriptional Start Site of the Chick iNOS

The primer extension analysis was applied to map the transcriptional initiation site of the chick iNOS gene. The avian myeloblastosis virus reverse transcriptase primer extension system from Promega was used with minor modifications. Total RNA was isolated from chicken macrophages, HD11 cells, stimulated with 100 ng/ml LPS or unstimulated. An oligonucleotide, GTTGTTCCCAAATCTGCTAG (see Fig. 4), complementary to the 5` end sequence of the chicken iNOS was end-labeled with P, and it was used as the primer. The primer annealing temperature was 50 °C for 1 h using 5 µg of total RNA. The reverse transcription was performed in using avian myeloblastosis virus reverse transcriptase at 41 °C for 1 h. The same primer was used in DNA sequencing on a plasmid containing the 5`-flanking region of chick iNOS gene. The sequencing product was run side by side as a molecular weight marker with the primer extension product in a 6% sequencing gel. The gel was dried, transferred to chromatography paper, and exposed overnight to an x-ray film. The transcription initiation site of the chick iNOS gene was obtained by aligning the size of the reverse transcription product with the DNA sequencing result.



Figure 4: Nucleotide sequence of the chicken iNOS 5`-flanking region. The mRNA initiation site is denoted as nucleotide position +1 which is bold. Intron 1 is enclosed with parentheses located from +86 to +182 (97 nucleotides). The complementary sequence of nucleotides, +52 to +71, was made as a primer (underlined arrow), 20 nucleotides long, for the primer extension experiment. A putative TATA box is located at nucleotide -30 (boxed). The region associated with LPS response was labeled with a vertical line. Potential transcription factor binding sites are underlined and labeled. All the transcription factor binding sites shown are perfect matches with reported consensus sequences.



Construction of a Reporter Gene with the Upstream Sequence of iNOS Gene

A 3.2-kb fragment of iNOS upstream sequence was cloned into a luciferase reporter gene, pGL2 Basic (Promega). The iNOS 5`-flanking sequence was excised from the plasmid by PvuII and SacI restriction enzymes. The excised fragment was incubated with Klenow enzyme to generate blunt ends for ligation into a luciferase reporter gene. A pGL2 luciferase reporter plasmid was linearized by the XhoI restriction enzyme and incubated with Klenow enzyme to generate blunt ends. The linearized and blunt end insert (iNOS 5` end fragment) and vector (pGL2) were incubated together in the presence of the ligation buffer and 1 µl of high concentration T4 ligase (15 units/µl) at 18 °C overnight. The ligation mixture was transformed into DH5alpha E. coli cells and spread on ampicillin agar plates. Six colonies were randomly picked from the plates, and their plasmids were isolated. The isolated plasmids were digested individually with restriction enzymes (HindIII and KpnI) to screen the clone containing the iNOS upstream fragment insert. The positive clones were sequenced to determine the orientation of the insert. The clone containing the correct orientation was used to generate deletion clones.

Construction of Deletion Clones

A series of deletion constructs were made from a chimeric plasmid containing the 3.2-kb 5` upstream region of the iNOS gene ligated in front of a luciferase gene by using a kit, Erase-a-Base system (Promega). The plasmid (20 µg) was digested with MluI and KpnI restriction enzymes to generate 5`- and 3`-protruding ends, respectively. Exonuclease III was used to digest the 5`-protruding end of DNA at 25 °C which would digest approximately 90 base pairs per min. An aliquot of DNA was taken every minute to obtain a spectrum of deletion clones. The partial digested DNA was then treated with S1 nuclease and Klenow enzyme to generate blunt ends. The DNA with two blunt ends were ligated together by T4 DNA ligase at room temperature for 1 h. The ligation mixture was transformed into E. coli DH5alpha competent cells. Plasmid was isolated from randomly picked colonies, and the size of deletion clones was estimated by PCR reaction by using the primers generated from pGL2 vector close to the polycloning sites. DNA sequencing was used to identify the exact size of the deletion clones.

Transient Expression of Deletion Clones

HD11 cells (1.8 times 10^6 cells/dish) were seeded in a 100-mm culture dish 24 h before transfection. Cells were kept in DMEM plus 10% fetal bovine serum and antibiotics at 37 °C in a 5% CO(2) incubator until cells were approximately 60% confluent. HD11 cells were then washed with DMEM buffer without serum and antibiotics three times prior to transfection. For every two 100-mm culture dishes, 4 µg of reporter DNA containing galactosidase gene as a control for transfection efficiency and 4 µg of reporter DNA containing various sizes of iNOS upstream sequence were used in transfection experiments. The two kinds of DNA were mixed well before being distributed into two tubes for transfection. Therefore, each tube contains 4 µg of DNA. LipofectAMINE (30 µl/tube) was then added to each tube. DNA and LipofectAMINE were mixed thoroughly and incubated at room temperature for at least 30 min prior to adding to cell culture dishes. HD11 cells were then incubated with DNA and LipofectAMINE mixture in DMEM without serum and antibiotics. Five hours after transfection, HD11 cells were harvested by scraping with a rubber policeman and pooled from two dishes. Transfected cells were washed twice with DMEM without serum and then reseeded into a 6-well culture dish in the presence or absence of 100 ng/ml LPS. 15 h after LPS treatment, cellular extract was isolated and luciferase and beta-galactosidase activities were measured.


RESULTS

Chicken Macrophage NOS Sequence

Oligonucleotide primers (see ``Materials and Methods'') designed from the conserved sequences between mouse macrophage NOS (31, 32) and rat brain NOS (24) were used to amplify by reverse transcription-PCR on total RNA from chicken macrophages stimulated with LPS (100 ng/ml). A partial chick type II NOS (iNOS) cDNA was obtained which was approximately 220 bp and showed 68% sequence identity with mouse iNOS cDNA and no sequence similarity to any other existing proteins in GenBank (data not shown). Thus, the PCR product was used as a probe to screen a chicken macrophage cDNA library. Approximately 1 million independent clones from an unamplified library were screened, and hundreds of positive clones were identified. After secondary and tertiary screening, 24 independent clones were isolated. A clone containing the longest insert was fully sequenced on both strands. It possessed an open reading frame which encoded 1,136 amino acid residues, predicting a protein of 129,648 Da molecular mass. The deduced amino acid sequence of chicken macrophage NOS was aligned with published NOS sequence by using MEGALIGN in DNA STAR, Lasergene (Fig. 1). There were conserved regions in deduced amino acid sequences of chicken iNOS for the binding of iNOS cofactors: heme, calmodulin, FMN, FAD, and NADPH.


Figure 1: The deduced amino acid sequence of chicken macrophage iNOS (CKiNOS) aligned with the amino acid sequences of murine macrophage iNOS (MUiNOS)(31, 32) , human chondrocyte iNOS (HUiNOS)(44) , bovine endothelial cNOS (BOeNOS)(28) , and rat neuronal c NOS (RAnNOS)(24) . Gaps introduced in the sequences to optimize alignments are shown as dots. The identical amino acids are shown as asterisks. Putative cofactor binding sites are drawn in boxes as indicated. CM, calmodulin binding site; Heme, heme binding site; FMN, FMN binding site; F, FAD binding site; N, NADPH binding site. The residues used to design the primers for polymerase chain reaction are shown in bold italic.



Table 1shows the percent identity (homology) of NOS protein sequences between different isoforms and species by using ``GAP'' algorithm in the GCG program. The deduced chicken macrophage NOS protein sequence showed 66.6% (79.1%), 70.4% (81.2%), 54.2% (71.7%), and 48.7% (66.1%) sequence identity (similarity) to mouse iNOS(31, 32) , human iNOS(44) , rat brain cNOS(24) , and bovine endothelium cNOS(30) , respectively. Among the three different isoforms of NOS, there is approximately 50% identity within the same species, e.g. identity among iNOS, eNOS, and nNOS in human. However, eNOS or nNOS among different species exhibited 93% identity, whereas the identity of iNOS among different species was about 81%. Thus, it appears that the percent identity among the same isoforms of NOS between species was considerably higher than that of different isoforms within the same species.



Northern Analysis

The Northern blot analysis (Fig. 2) showed the chicken iNOS mRNA possesses a molecular size of approximately 4.5 kb, and the highest accumulation of NOS message at 6-12 h after LPS treatment of HD11 cells. After 12 h, the NOS mRNA abundance decreased and approached the basal levels by 24 h. The chicken macrophage iNOS mRNA molecular mass resembles that of the mouse macrophage iNOS (4.5 kb) and is different from the rat brain constitutive NOS mRNA (9.5 kb)(24) .


Figure 2: Northern blot analysis of total RNA from endotoxin-treated HD11 chicken macrophages. Total RNA was obtained from chicken macrophages treated with LPS for 0, 4, 8, 12, or 24 h respectively (lanes 1-5), and 30 µg of total RNA was loaded in each lane. The results indicate that NOS mRNA accumulated from 0-12 h after cells were treated with LPS; the most NOS mRNA was at the 12-h time point, and, at 24 h, NOS mRNA was decreased.



Transient Expression

To investigate whether the clone obtained is functional, transient transfection experiments were performed (Fig. 3). Transfection into COS-1 cells of the clone in the sense direction resulted in significant nitrite production, whereas the nitrite production in cells transfected with antisense or vector DNA was undetectable. Furthermore, inhibitors for iNOS, L-NMMA, and aminoguanidine (100 µM) were capable of blocking the production of nitrite in COS cells transfected with chicken iNOS cDNA oriented in the sense direction. The inhibition by L-NMMA and aminoguanidine could be overcome partially by incubation of cells with excess L-arginine (1 mM) but not D-arginine (1 mM) (Fig. 3).


Figure 3: Transient expression of chicken iNOS cDNA. NOS activity in COS-1 cells transfected with chicken iNOS cDNA which was cloned into an expression vector, pcDNA 3 (Invitrogen), in a sense direction or antisense direction as assessed 48 h after transfection. NO(2) was measured as indicated under ``Materials and Methods.'' In COS-1 cells transfected with sense direction, NOS specific inhibitors, L-NMMA or aminoguanidine (100 µM), were added in culture medium with or without L-arginine or D-arginine (1 mM). Each data point was a mean ± S.E. obtained from four samples. These data were similar in three independent experiments.



iNOS 5`-Flanking Sequence

After screening an amplified chicken genomic library, eight positive clones were identified. These eight positive clones belonged to four independent clones as determined by restriction analysis (data not shown). An approach using PCR (see ``Materials and Methods'') was used to identify the clone containing the 5`-flanking region of chicken iNOS gene. After identifying the clones which possessed the upstream sequence of iNOS gene, they were subcloned into Bluescript plasmids by four different restriction enzymes. Applying the same PCR approach to identify randomly picked colonies from these four subcloning groups, two colonies were found to possess the upstream sequence of iNOS gene. A total of 3,145 bp of the upstream region of chicken iNOS gene (Fig. 4) was obtained. Comparing the genomic sequences to iNOS cDNA sequences, an intron (97 bp) was identified. This intron was located between +86 and +182 bp.

The mRNA transcription initiation site, designated nucleotide +1, was identified by primer extension analysis using total RNA from LPS-stimulated HD11 cells (Fig. 5). There was no band in the same primer extension analysis by applying total RNA isolated from unstimulated HD11 cells (lane U). A putative TATA box was identified at 30 bp upstream of the transcription initiation site. Comparing the sequence identity of the 300 bases upstream of the transcription start site of chicken iNOS gene to that of human and mouse iNOS genes showed 39.8% and 35% identity, respectively.


Figure 5: Primer extension analysis to map the chicken iNOS mRNA initiation site. The oligonucleotides, 20-mers, as indicated in Fig. 4were used in the study. Total RNA isolated from HD11 cells with or without LPS treatment was hybridized to the P-end-labeled primer. The primer was extended with avian myeloblastosis virus reverse transcriptase, and the products were electrophoresed on a 6% sequencing gel along with a dideoxy sequencing ladder applying the same primer. The primer extension using RNA from unstimulated HD11 cells was denoted U; RNA induced by LPS stimulation was denoted as I.



Deletion Analysis

The chicken 5`-flanking sequence was ligated in front of a luciferase gene (a basic form without promoter and enhancer). Serial deletion clones were generated by exonuclease III digestion. The precise deletion site was determined by DNA sequencing analysis. These deletion clones along with a control gene, beta-galactosidase, were transfected into chicken macrophages, HD11. Transfected cells were treated with LPS, and the activities of luciferase and beta-galactosidase were determined 15 h after LPS treatment. When the clone containing the longest 5` sequences of chicken iNOS gene was transfected into HD11 cells, LPS induced luciferase activity by 100-fold compared to that of the clone containing minimum 5`-flanking sequences (Fig. 6). Slightly greater LPS-induced luciferase activity (178-fold) was observed when only 267 bp of the upstream sequence remained in front of a luciferase gene. There was a 5.4-fold reduction of LPS-induced luciferase activity (relative luciferase activity from 178.5 to 33.8) when comparing 179 bp to 267 bp of the upstream sequences of the iNOS gene. When an additional 85 bases were deleted (-179 bp to -94 bp), the LPS-induced luciferase activity was abolished. Computer analysis of transcription factor binding motifs from -280 bp to +1 bp relevant to LPS stimulation were shown (Fig. 4). These include: C/EBP, PEA1, PEA3, and NF-kappaB binding motifs.


Figure 6: Deletion analysis of the 5`-flanking region of the chicken iNOS gene. Progressive 5` end deletions of chicken iNOS promoter were ligated in front of the luciferase gene, and transfected into chicken macrophages, HD11, along with control plasmid, beta-galactosidase. Transfected cells were stimulated with medium alone or in the presence of LPS (100 ng/ml) for 15 h. Activities of luciferase and beta-galactosidase were determined (as described under ``Materials and Methods''). The luciferase activities were normalized by dividing the activities of beta-galactosidase to adjust the transfection efficiency. The clone containing the longest iNOS promoter in front of the luciferase gene was assigned as 100 as relative luciferase. LPS treatment did not affect beta-galactosidase activity (data not shown). Data are means ± S.E. of triplicates from 2-3 independent experiments.



Functional Analysis using PDTC

To investigate the potential role of nuclear factor NF-kappaB in the induction of the chicken iNOS gene, we employed the NF-kappaB specific inhibitor(45) , PDTC, in chicken macrophage cell culture. PDTC reduced nitrite production by 100% in the presence of 40 µM PDTC in LPS-treated HD11 cells (Fig. 7A). Therefore, 40 µM PDTC was chosen to examine its effect on NOS mRNA accumulation. As shown in Fig. 7B, 12 h after HD11 cells were treated with LPS alone, a marked accumulation of NOS mRNA was observed. When cells were treated with LPS in the presence of PDTC (lane 4), there was little accumulation of NOS mRNA. This clearly demonstrated that PDTC blocked substantially the accumulation of iNOS mRNA in chicken macrophage cells, and thus is a result similar to that reported for mouse macrophages(46) .


Figure 7: The effect of pyrrolidine dithiocarbamate (PDTC) on the synthesis of nitrite and the accumulation of iNOS mRNA in chicken macrophages. A, HD11 cells were treated with LPS (100 ng/ml) in the presence of various amounts of PDTC as indicated in the figure. Nitrite concentration was determined 48 h after treatment. Values from cells treated with LPS only were set as 0% inhibition. Data were obtained from duplicate wells. B, Northern blot analysis of HD11 cells treated with or without LPS (100 ng/ml) together with or without PDTC (40 µM) as shown in the figure. Total RNA was isolated 12 h after treatment, and 10 µg of total RNA was loaded in each lane. The ethidium bromide staining showed equal loading of total RNA across samples.




DISCUSSION

We report herein the first nonmammalian inducible NOS cDNA isolated from chicken macrophages. Our data show that NOS is moderately conserved overall, and it is highly conserved with respect to critical cofactor binding sequences. We also identified approximately 3.2 kb of the upstream region of the chicken iNOS gene. From the deletion study (Fig. 6), we show that LPS responsive elements are located exclusively within 300 bp upstream of the transcription initiation site. Within these 300 bp, several consensus DNA binding elements were identified for transcriptional factors which may be regulated by LPS. NF-kappaB was identified as a potentially important transcription factor since both mouse and human iNOS (31, 32, 44) contain this response element. The results from the deletion and inhibitor studies ( Fig. 6and Fig. 7) appear to indicate that NF-kappaB is indeed a required nuclear factor to activate the chicken iNOS gene expression by LPS.

The chicken iNOS amino acid sequence is approximately 70% identical with mammalian inducible forms of NOS. Assuming divergence of chickens and mammals at approximately 220 million years(47) , the rate of evolution can be calculated to be approximately 12 residues/100 million years. This rate of evolution is comparable to that described for histone H1 protein (47) and metallothionein(48) , greater than some proteins like histone H4, H3, H2A, and H2B (0.25, 0.30, 1.7, and 1.7 residues/100 million years), cytochrome c (6.7 residues/100 million years), and insulin (7.1 residues/100 million years) and lower than other proteins like albumin, hemoglobin alpha and beta, lysozymes, and fibrinopeptide B (20, 27, 30, 40, 91 residues/100 million years, respectively). This analysis suggests that the rate of evolution of the iNOS is moderate. Furthermore, upon comparing the different isoforms of NOS among several different species, the percent identity between the same isoform among the different species is considerably higher than different isoforms within the same species. This suggests that the same isoform among different species was derived from the same ancestral gene and that the different isoforms of NOS evolved earlier than the separation of species.

Recently, a bidomain structure of rat brain NOS protein was suggested by Sheta et al.(49) . The authors demonstrated that nNOS can be isolated in two functionally intact subunits. We were interested to determine whether there is a difference in the conservation within these two domains and therefore examined the chicken macrophage NOS protein sequence by individual domains. The N-terminal domain of chicken iNOS, the sequence before the putative calmodulin binding site, showed 73% to 61% identity to all published NOS sequences and no sequence similarity to other known proteins. The C-terminal domain of chicken iNOS also showed similar sequence identity to all the published NOS sequences (66% to 49%) and high sequence similarity to P450 reductase (50) and ferrodoxin reductase(51) . Thus, the two domains of iNOS appear to be equally conserved. Since the putative calmodulin (52) and heme (53) binding sites were highly conserved, this suggests that the N-terminal domain of NOS assumes a function unique to NOS with no similarity to other known enzymes. When aligned with the ferridoxin reductase sequence(54, 55) , the published NOS protein sequences were highly conserved at the NADH and FAD cofactor binding sequences (Fig. 1). This reinforces the notion that the catalytic function of the C-terminal domain of NOS is to transfer electrons to heme moiety binding at the N-terminal domain.

The transcription initiation site of chicken iNOS was identified to be a single start site, G nucleotide, by primer extension. There is a putative TATA box, 30 bp upstream of the transcriptional initiation site which is identical with the mouse (30 bp) and human (30 bp) iNOS genes(56, 57, 58) . Furthermore, when total RNA from unstimulated chicken macrophages was used in primer extension analysis, there was no detectable iNOS mRNA. This result confirmed the data seen in the Northern blot analysis and reinforced the observation that the accumulation of chicken macrophage iNOS mRNA is induced by LPS.

The 5`-flanking region, 3,145 bp, of chicken iNOS gene conferred inducibility by LPS. The major finding of the present study is that a 267-bp upstream region contained complete LPS inducibility. The relative luciferase activity of a reporter gene containing 267 bp of the upstream region of the iNOS gene responded fully to LPS stimulation and was not enhanced by the additional 5`-flanking sequence. Thus, the 267 bp upstream of iNOS gene seemed to contain the elements essential for endotoxin-induced transcriptional activation. Moreover, this region can be divided into two subregions: subregion I, -179 bp to -93 bp and subregion II, -267 bp to -179 bp based on the differential activity following LPS activation.. The clone containing minimum 5`-flanking sequences, -93 bp to +259 bp, failed to exhibit any promoter activity as stimulated by LPS. With the addition of subregion I in front of this minimum 5`-flanking region, there was a 34-fold increase in LPS-induced luciferase activity as compared to that of the clone with minimum 5`-flanking sequences. When subregion II was also present, LPS induced luciferase activity by an additional 5-fold which then totaled a 178-fold increase in LPS-induced luciferase activity when compared to the minimum 5`-flanking sequence. This result suggested that only subregions I and II are required for maximum induction of iNOS gene transcription by endotoxin. Again, this result contrasts observations reported for the mouse macrophage NOS where two distinctly separated regions (-1029 to -913 and -209 to -48) were identified(58) .

Analyzing the chicken LPS-sensitive regions revealed several consensus elements for transcription factors which may be responsible for LPS stimulation. Subregion I contains NF-kappaB (59) and C/EBP consensus binding elements(60) . NF-kappaB has also been shown to exist in the promoters of mouse (56, 58) and human (57) iNOS genes. Moreover, NF-kappaB has been shown to be a required nuclear factor for the induction of mouse iNOS gene by LPS(46) . In the present study, the NF-kappaB inhibitor, PDTC, was able to block almost completely both nitrite accumulation in culture medium and NOS mRNA accumulation in LPS-stimulated macrophages. This result suggests that NF-kappaB is also functionally involved in the transcriptional regulation or activation of chicken iNOS gene by LPS. From our data and those of the mouse, we might predict that either the NF-kappaB consensus element is also functionally significant in human iNOS promoter. If not, then the human iNOS gene represents a unique iNOS system relative to mouse and avian. Subregion II of the chicken promoter contains PEA1 and PEA3 consensus binding elements(61, 62) . These elements have been shown in the enhancer region of polyomavirus, and they are important for polyomavirus DNA replication and RNA transcription(63, 64) . PEA1 and PEA3 also appear in the upstream region of collagenase gene(65) , and they have been demonstrated to modulate 12-O-tetradecanoylphorbol-13-acetate induction of collagenase gene. However, PEA1 and PEA3 are not present in the promoters of mouse and human iNOS genes. Further studies are needed to characterize the promoter sequence of chicken iNOS gene in detail to gain a greater understanding of the mechanisms that regulate chicken iNOS gene expression.

The early portion (400 bp) of the 5`-flanking region of human iNOS gene is approximately 67% identical with the mouse iNOS gene(57) . Although this upstream sequence of iNOS gene between human and mouse shares high sequence similarity, there is as yet no functional analysis of the 5`-flanking region of human iNOS gene. The 5`-flanking region of chicken iNOS gene was shown in the present study to contain the LPS-responsive region within 300 bp upstream of the transcription initiation site. When comparing the sequence identity between this 300 bp of 5`-flanking sequences of chicken iNOS gene with that of mouse or human iNOS genes, there was a low identity: 35% to mouse iNOS gene and 39.8% to human iNOS gene. Essentially, the data suggest that there is little sequence identity in 300 bp of 5`-flanking sequences of chicken iNOS gene compared with those of mouse or human iNOS genes. On the other hand, the promoter sequences of the chicken, mouse, and human iNOS genes show: 1) a TATA box located at 30 bp upstream of the transcription initiation site, 2) an NF-kappaB response element located at approximately 100 bp upstream of the transcription initiation site. Moreover, both chicken and mouse iNOS genes have been demonstrated to possess functional LPS-responsive activity within 300 bp upstream of the transcription initiation site. This indicates that the avian iNOS promoter shares both similarities and differences to the mammalian iNOS promoters. The similarities would suggest that either the 400-bp upstream region of the human iNOS gene is functionally important or that the human gene is uniquely different.

In summary, we have cloned the first nonmammalian iNOS cDNA from a chicken macrophage cell line. The sequence comparison showed that chicken iNOS protein sequence is approximately 70% identical with mammalian iNOS. The rate of evolution of the iNOS protein, overall, appears to be moderate. The molecular size of chicken macrophage iNOS mRNA (4.5 kb) is comparable to the mammalian iNOS. Functional analysis of 3.2 kb of the 5`-flanking sequences of chicken iNOS gene showed a LPS-responsive region located exclusively within 300 bp upstream of the transcription initiation site, a result in marked contrast to that of mouse iNOS gene(56, 58) . Also, when comparing the sequences of these 300 bp between chicken iNOS gene to that of mouse (or human) gene, there was low identity (35%). Several consensus sequences for transcription factors were identified: NF-kappaB, C/EBP, PEA1, and PEA3. Using a NF-kappaB inhibitor, PDTC, NF-kappaB was shown to be involved in the LPS-induced iNOS gene expression, a result similar to that of mouse iNOS gene. The similarities and differences observed between the promoters of chicken iNOS gene and those of human and mouse iNOS genes may provide insight into the molecular mechanisms that regulate the expression of iNOS and the factors that influence the expression patterns of iNOS in different species.

Note Added in Proof-deVera et al.(67) recently reported an analysis of the human iNOS promoter.


FOOTNOTES

*
This work was supported by Cornell University and United States Department of Agriculture Project NYC-199409. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) U46504 [GenBank](cDNA) and U46503 [GenBank ](5`-flanking genomic).

§
To whom correspondence should be addressed: Division of Nutritional Sciences, 223 Savage Hall, Cornell University, Ithaca, NY 14853. Tel.: 607-255-0797; Fax: 607-255-1033; ccm3{at}cornell.edu.

(^1)
The abbreviations used are: NO, nitric oxide; NOS, nitric-oxide synthase; eNOS, endothelial nitric-oxide synthase; iNOS, inducible nitric-oxide synthase; nNOS, neuronal nitric-oxide synthase; C/EBP, CCAAT/enhancer-binding protein; L-NMMA, N^G-monomethylarginine; LPS, lipopolysaccharide; PDTC, pyrrolidine dithiocarbamate; PEA1 and PEA3, polyomavirus enhancer activator 1 and 3; DMEM, Dulbecco's modified Eagle's medium; PCR, polymerase chain reaction; kb, kilobase(s); bp, base pair(s); PIPES, 1,4-piperazinediethanesulfonic acid.


REFERENCES

  1. Moncada, S. (1992) Acta Physiol. Scand. 145, 201-227 [Medline] [Order article via Infotrieve]
  2. Hibbs, J. B. (1991) Res. Immunol. 142, 565-569 [CrossRef][Medline] [Order article via Infotrieve]
  3. Marletta, M. A. (1993) J. Biol. Chem. 268, 12231-12234 [Free Full Text]
  4. Snyder, S. H., and Bredt, D. S. (1992) Sci. Am. 266, 68-77 [Medline] [Order article via Infotrieve]
  5. Nathan, C. (1992) FASEB J. 6, 3051-3064 [Abstract/Free Full Text]
  6. Feldman, P. L., Griffith, O. W., and Stuehr, D. J. (1993) Chem. Eng. News 20, 26-38
  7. Gibaldi, M. (1993) J. Clin. Pharmacol. 33, 488-496 [Abstract/Free Full Text]
  8. Knowles, R. G., and Moncada, S. (1994) Biochem. J. 298, 249-258 [Medline] [Order article via Infotrieve]
  9. Bredt, D. S., and Snyder, S. H. (1992) Neuron 8, 3-11 [Medline] [Order article via Infotrieve]
  10. Snyder, S. H. (1992) Science 257, 494-496 [Medline] [Order article via Infotrieve]
  11. Hoffman, M. (1991) Science 252, 1788 [Medline] [Order article via Infotrieve]
  12. Ignarro, L. J. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 535-560 [CrossRef][Medline] [Order article via Infotrieve]
  13. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., and Chaudhuri, G. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 9265-9269 [Abstract]
  14. Radomski, M. W., and Moncada, S. (1993) Adv. Exp. Med. Biol. 344, 251-264 [Medline] [Order article via Infotrieve]
  15. Stark, M. E., and Szurszewski, J. H. (1992) Gastroenterology 103, 1928-1949 [Medline] [Order article via Infotrieve]
  16. Billiar, T. R., Hoffman, R. A., Curran, R. D., Langrehr, J. M., and Simmons, R. L. (1992) J. Lab. Clin. Med. 120, 192-197 [Medline] [Order article via Infotrieve]
  17. Corbett, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R., Jr., and McDaniel, M. L. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 1731-1735 [Abstract]
  18. Cattell, V., and Cook, H. T. (1993) Exp. Nephrol. 1, 265-280 [Medline] [Order article via Infotrieve]
  19. Schmidt, H. H. H. W., and Walter, U. (1994) Cell 78, 919-925 [Medline] [Order article via Infotrieve]
  20. Bredt, D. S., and Snyder, S. H. (1990) Proc. Natl. Acad. Sci. 87, 682-685 [Abstract]
  21. Schmidt, H. H. H. W., Pollock, J. S., Nakane, M., Gorsky, L. D., Förstermann, U., and Murad, F. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 365-369 [Abstract]
  22. Stuehr, D. J., Cho, H. J., Kwon, N. S., Weise, M. F., and Nathan, C. F. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 7773-7777 [Abstract]
  23. Evans, T., Carpenter, A., and Cohen, J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 5361-5365 [Abstract]
  24. Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., and Snyder, S. H. (1991) Nature 351, 714-718 [CrossRef][Medline] [Order article via Infotrieve]
  25. Nakane, M., Schmidt, H. H. H. W., Pollock, J. S., Förstermann, U., and Murad, F. (1993) FEBS Lett. 316, 175-180 [CrossRef][Medline] [Order article via Infotrieve]
  26. Ischiropoulos, H., Zhu, L., and Beckman, J. S. (1992) Arch. Biochem. Biophys. 298, 446-451 [Medline] [Order article via Infotrieve]
  27. Janssens, S. P., Shimouchi, A., Quertermous, T., Bloch, D. B., and Bloch, K. D. (1992) J. Biol. Chem. 267, 14519-14522 [Abstract/Free Full Text]
  28. Sessa, W. C., Harrison, J. K., Barber, C. M., Zeng, D., Durieux, M. E., D'Angelo, D. D., Lynch, K. R., and Peach, M. J. (1992) J. Biol. Chem. 267, 15274-15276 [Abstract/Free Full Text]
  29. Nishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S. P., Uematsu, M., Nerem, R. M., Alexander, R. W., and Murphy, T. J. (1992) J. Clin. Invest. 90, 2092-2096 [Medline] [Order article via Infotrieve]
  30. Lamas, S., Marsden, P. A., Li, G. K., Tempst, P., and Michel, T. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 6348-6352 [Abstract]
  31. Lyons, C. R., Orloff, G. J., and Cunningham, J. M. (1992) J. Biol. Chem. 267, 6370-6374 [Abstract/Free Full Text]
  32. Xie, Q. W., Cho, H. J., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A. H., Troso, T., and Nathan, C. (1992) Science 256, 225-228 [Medline] [Order article via Infotrieve]
  33. Geller, D. A., Lowenstein, C. J., Shapiro, R. A., Nussler, A. K., Di Silvio, M., Wang, S. C., Nakayama, D. K., Simmons, R. L., Snyder, S. H., and Billiar, T. R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3491-3495 [Abstract]
  34. Cho, H. J., Xie, Q. W., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., and Nathan, C. (1992) J. Exp. Med. 176, 599-604 [Abstract]
  35. Nathan, C., and Xie, Q. (1994) J. Biol. Chem. 269, 13725-13728 [Free Full Text]
  36. Ribeiro, J. M. C., Hazzard, J. M. H., Nussenzveig, R. H., Champagne, D. E., and Walker, F. A. (1993) Science 260, 539-541 [Medline] [Order article via Infotrieve]
  37. Holmqvist, B. I., Östholm, T., Alm, P., and Ekström, P. (1994) Neurosci. Lett. 171, 205-208 [CrossRef][Medline] [Order article via Infotrieve]
  38. Sung, Y. J., Hotchkiss, J. H., Austic, R. E., and Dieter, R. R. (1991) J. Leukocyte Biol. 50, 49-56 [Abstract]
  39. Regulski, M., and Tully, T. (1996) Proc. Natl. Acad. Sci. U. S. A. 92, 9072-9076 [Abstract]
  40. Tamir, H., and Ratner, S. (1963) Arch. Biochem. Biophys. 102, 249-258
  41. Beug, H., von Krichbach, A., Doderlein, G., Conscience, J., and Graf, T. (1979) Cell 18, 375-390 [Medline] [Order article via Infotrieve]
  42. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159 [CrossRef][Medline] [Order article via Infotrieve]
  43. Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R. (1982) Anal. Biochem. 126, 131-138 [Medline] [Order article via Infotrieve]
  44. Charles, I. G., Palmer, R. M. J., Hickery, M. S., Bayliss, M. T., Chubb, A. P., Hall, V. S., Moss, D. W., and Moncada, S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11419-11423 [Abstract]
  45. Coyle, P., Philcox, J. C., and Rofe, A. M. (1995) Biochem. J. 309, 25-31 [Medline] [Order article via Infotrieve]
  46. Xie, Q., Kashiwabara, Y., and Nathan, C. (1994) J. Biol. Chem. 269, 4705-4708 [Abstract/Free Full Text]
  47. Wilson, A. C., Carlson, S. S., and White, T. (1977) Annu. Rev. Biochem. 46, 573-639 [CrossRef][Medline] [Order article via Infotrieve]
  48. McCormick, C. C., Fullmer, C. S., and Garvey, J. S. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 309-313 [Abstract]
  49. Sheta, E. A., McMillan, K., and Masters, B. S. S. (1994) J. Biol. Chem. 269, 15147-15153 [Abstract/Free Full Text]
  50. Porter, T. D., and Kasper, C. B. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 973-977 [Abstract]
  51. Karplus, P. A., Walsh, K. A., and Herriott, J. R. (1984) Biochemistry 23, 6576-6583 [Medline] [Order article via Infotrieve]
  52. Vorherr, T., Knöpfel, L., Hofmann, F., Mollner, S., Pfeuffer, T., and Carafoli, E. (1993) Biochemistry 32, 6081-6088 [Medline] [Order article via Infotrieve]
  53. Mcmillan, K., Bredt, D. S., Hirsch, D. J., Snyder, S. H., Clark, J. E., and Masters, B. S. S. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11141-11145 [Abstract]
  54. Andrews, S. C., Shipley, D., Keen, J. N., Findlay, J. B. C., Harrison, P. M., and Guest, J. R. (1992) FEBS Lett. 302, 247-252 [CrossRef][Medline] [Order article via Infotrieve]
  55. Karplus, P. A., Daniels, M. J., and Herriott, J. R. (1991) Science 251, 60-66 [Medline] [Order article via Infotrieve]
  56. Xie, Q., Whisnant, R., and Nathan, C. (1993) J. Exp. Med. 177, 1779-1784 [Abstract]
  57. Chartrain, N. A., Geller, D. A., Koty, P. P., Sitrin, N. F., Nussler, A. K., Hoffman, E. P., Billiar, T. R., Hutchinson, N. I., and Mudgett, J. S. (1994) J. Biol. Chem. 269, 6765-6772 [Abstract/Free Full Text]
  58. Lowenstein, C. J., Alley, E. W., Raval, P., Snowman, A. M., Snyder, S. H., Russell, S. W., and Murphy, W. J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9730-9734 [Abstract]
  59. Lenardo, M. J., and Baltimore, D. (1989) Cell 58, 227-229 [Medline] [Order article via Infotrieve]
  60. Marcinkiewicz, J., Grabowska, A., and Chain, B. (1995) Eur. J. Immunol. 25, 947-951 [Medline] [Order article via Infotrieve]
  61. Kugiyama, K., Kerns, S. A., Morrisett, J. D., Roberts, R., and Henry, P. D. (1990) Nature 344, 160-162 [CrossRef][Medline] [Order article via Infotrieve]
  62. Murohara, T., Kugiyama, K., Ohgushi, M., Sugiyama, S., Ohto, Y., and Yasue, H. (1994) Am. J. Physiol. 267, H2441-H2449
  63. Bachmann, S., Bosse, H. M., and Mundel, P. (1995) Am. J. Physiol. 268, F885-F898
  64. Nishimura, J. S., Martasek, P., McMillan, K., Salerno, J. C., Liu, Q., Gross, S. S., and Masters, B. S. S. (1995) Biochem. Biophys. Res. Commun. 210, 288-294 [CrossRef][Medline] [Order article via Infotrieve]
  65. Dimmitt, S. B. (1995) Clin. Exp. Pharmacol. Physiol. 22, 204-208 [Medline] [Order article via Infotrieve]
  66. Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M., Sundell, C. L., Wilcox, J. N., Lamas, S., and Michel, T. (1992) FEBS Lett. 307, 287-293 [CrossRef][Medline] [Order article via Infotrieve]
  67. deVera, M. E., Shapiro, R. A., Nussler, A. K., Mudgett, J. S., Simmons, R. L., Morris, S. M., Jr., Billiar, T. R., and Geller, D. A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 1054-1059 [Abstract/Free Full Text]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.